BIT
CYTK icon

BlackRock Institutional Trust’s Cytokinetics CYTK Stock Holding History

BlackRock Institutional Trust’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$13.4M Buy
1,103,756
+15,997
+1% +$170K ﹤0.01% 2228
2016
Q3 		$9.99M Sell
1,087,759
-21,454
-2% -$224K ﹤0.01% 2333
2016
Q2 		$10.5M Sell
1,109,213
-213,001
-16% -$1.75M ﹤0.01% 2261
2016
Q1 		$9.32M Buy
1,322,214
+8,713
+0.7% +$63.7K ﹤0.01% 2303
2015
Q4 		$13.7M Sell
1,313,501
-168,834
-11% -$1.66M ﹤0.01% 2118
2015
Q3 		$9.92M Buy
1,482,335
+43,780
+3% +$299K ﹤0.01% 2308
2015
Q2 		$9.67M Sell
1,438,555
-27,884
-2% -$183K ﹤0.01% 2428
2015
Q1 		$9.94M Buy
1,466,439
+488
+0% +$3.64K ﹤0.01% 2392
2014
Q4 		$11.7M Buy
1,465,951
+32,887
+2% +$141K ﹤0.01% 2272
2014
Q3 		$5.04M Buy
1,433,064
+91,876
+7% +$386K ﹤0.01% 2688
2014
Q2 		$6.41M Buy
1,341,188
+154,816
+13% +$945K ﹤0.01% 2661
2014
Q1 		$11.3M Buy
1,186,372
+239,466
+25% +$2.17M ﹤0.01% 2343
2013
Q4 		$6.16M Buy
946,906
+62,392
+7% +$410K ﹤0.01% 2688
2013
Q3 		$6.7M Buy
+884,514
New +$9.49M ﹤0.01% 2583

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Institutional Trust's CYTK Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Cytokinetics (CYTK) stake by 1.5% in Q4 2016, buying an estimated $170K and bringing the position to 1,103,756 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2228.

BlackRock Institutional Trust first reported a position in CYTK in Q3 2013 and has held it in 14 quarters since. The position peaked at $13.7M in Q4 2015. 101 funds tracked by Wall St. Rank hold CYTK as of Q4 2016.

  • BlackRock Institutional Trust held 1,103,756 shares of Cytokinetics worth $13.4M as of Q4 2016.
  • BlackRock Institutional Trust bought 15,997 Cytokinetics shares in Q4 2016, an estimated $170K.
  • Cytokinetics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2228 holding.
  • BlackRock Institutional Trust first reported a position in Cytokinetics in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Institutional Trust's Cytokinetics position peaked at $13.7M in Q4 2015.
  • 101 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.